FIGURE 5 from Synergism Between IL21 and Anti-PD-1 Combination Therapy is Underpinned by the Coordinated Reprogramming of the Immune Cellular Network in the Tumor Microenvironment
IL21-anti-HSA and anti-PD-1 mAb administration drives phenotypic polarization and clonal expansion of Treg cells. A, UMAP showing Treg cell subsets, including pre-eTreg cells, eTreg cells, and cycling Treg cells. B, Contour heat map of Treg cell subsets split by different treatment conditions. C, Bar plot of Treg cell subsets under different treatment conditions. D, Heat map showing expression of selected DEGs in Treg cells. E, TCR clonal expansion fractions and average clonal sizes of total Treg cells under different treatment conditions.